HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 31 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,194 | +39.6% | 13,128 | -46.1% | 0.00% | – |
| Q4 2022 | $7,303 | -43.8% | 24,336 | -7.2% | 0.00% | – |
| Q3 2022 | $13,000 | -13.3% | 26,236 | +2.7% | 0.00% | – |
| Q2 2022 | $15,000 | -75.8% | 25,536 | -46.7% | 0.00% | – |
| Q1 2022 | $62,000 | +34.8% | 47,903 | +18.4% | 0.00% | – |
| Q4 2021 | $46,000 | +4.5% | 40,455 | +41.3% | 0.00% | – |
| Q3 2021 | $44,000 | -71.1% | 28,624 | -62.7% | 0.00% | – |
| Q2 2021 | $152,000 | -22.1% | 76,699 | -27.6% | 0.00% | – |
| Q1 2021 | $195,000 | +1850.0% | 105,971 | +2254.9% | 0.00% | – |
| Q4 2020 | $10,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |